Service de pharmacologie clinique

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


580 publications

Sous presse | 2024 | 2023 | 2022 | 2021 | ...
Sous presse
 
Acute aseptic meningitis temporally associated with trimethoprim and sulfamethoxazole: Systematic review.
Bernasconi G.F., Milani G.P., De Felice ELT, Laurence C., Faré P.B., Terziroli Beretta-Piccoli B., Bianchetti M.G., Lava SAG British journal of clinical pharmacology. Peer-reviewed.
[DOI][Pmid][serval:BIB_FED6CF57F4CC]
 
Drug-drug interactions potential with the HIV-1 capsid inhibitor lenacapavir.
Marzolini C., Gibbons S., Seddon D., Khoo S. Expert opinion on drug metabolism & toxicology. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8322AB5A633B]
 
Population pharmacokinetic modelling of cetirizine concentrations in human breast milk-A contribution from the ConcePTION project.
Melander E., Nielsen E.I., Lindqvist A., Hovd M., Gandia P., Panchaud A., Guidi M., Annaert P., Baranczewski P., Spigset O. et al. Basic & clinical pharmacology & toxicology. Peer-reviewed.
[DOI][Pmid][serval:BIB_A52B902F4CE9]
 
Microvascular Inflammation of Kidney Allografts and Clinical Outcomes
Sablik Marta, Sannier Aurélie, Raynaud Marc, Goutaudier Valentin, Divard Gillian, Astor Brad C., Weng Patricia, Smith Jodi, Garro Rouba, Warady Bradley A. et al. New England Journal of Medicine.
[DOI][Pmid][serval:BIB_032D35160D0D]
 
Importance of sex-dependent differences for dosing selection and optimization of chemotherapeutic drugs
Seydoux Claire, Briki Myriam, Wagner Anna D., Choong Eva, Guidi Monia, Carrara Sandro, Thoma Yann, Livio Françoise, Girardin François R., Marzolini Catia et al. Chemotherapy. Peer-reviewed.
[DOI][serval:BIB_84F759610A36]
 
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells.
Sáez-Cirión A., Mamez A.C., Avettand-Fenoel V., Nabergoj M., Passaes C., Thoueille P., Decosterd L., Hentzien M., Perdomo-Celis F., Salgado M. et al. Nature medicine. Peer-reviewed.
[DOI][Pmid][serval:BIB_2BCEBE82B4CC]
 
The Impact of Dexamethasone and Prednisone on Apixaban and Rivaroxaban Exposure in COVID-19 Patients: A Physiologically Based Pharmacokinetic Modeling Study.
Terrier J., Abouir K., Gaspar F., Daali Y., Samer C.F. Clinical pharmacology and therapeutics. Peer-reviewed.
[DOI][Pmid][serval:BIB_C097DC7C220D]
 
Retraction Note: Influence of hypobaric hypoxia on leptin levels in men.
Tschöp M., Strasburger C.J., Töpfer M., Hautmann H., Riepl R., Fischer R., Hartmann G., Morrison K., Appenzeller M., Hildebrandt W. et al. International journal of obesity. Peer-reviewed.
[DOI][Pmid][serval:BIB_AED9B103123E]
2024
 
Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer
Poinot Hélène, Dupuychaffray Eloïse, Arnoux Grégoire, Alvarez Montserrat, Tachet Jérémie, Ezzar Ounss, Moore Jonathan, Bejuy Olivia, Olesti Eulalia, Visconti Gioele et al., 2024/12/31. OncoImmunology, 13 (1). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3D9433D4F7E9]
 
State of the art of real-life concentration monitoring of rifampicin and its implementation contextualized in resource-limited settings: the Tanzanian case.
Petermann Y.J., Said B., Cathignol A.E., Sariko M.L., Thoma Y., Mpagama S.G., Csajka C., Guidi M., 2024/12. JAC-antimicrobial resistance, 6 (6) pp. dlae182. Peer-reviewed.
[DOI][Pmid][serval:BIB_CCFBA0899F39]
 
Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIV
Thoueille Paul, Saldanha Susana Alves, Schaller Fabian, Choong Eva, Veuve François, Munting Aline, Cavassini Matthias, Braun Dominique, Günthard Huldrych F., Duran Ramirez Jessy J. et al., 2024/11/15. Frontiers in Pharmacology, 15. Peer-reviewed.
[DOI][serval:BIB_9DDB05C5BD5C]
A population pharmacokinetic model for sertraline in women during the perinatal period-A contribution from the ConcePTION project.
Monfort A., Cardoso E., Eap C.B., Ansermot N., Crettol S., Fischer Fumeaux C.J., Graz M.B., Harari M.M., Weisskopf E., Gandia P. et al., 2024/11. British journal of clinical pharmacology, 90 (11) pp. 2849-2860. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_09F8B14E5C96]
 
Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression: Results Through Week 144 of the SIMPL'HIV Trial.
Marinosci A., Sculier D., Wandeler G., Yerly S., Stoeckle M., Bernasconi E., Braun D.L., Vernazza P., Cavassini M., Decosterd L. et al., 2024/11. Open forum infectious diseases, 11 (11) pp. ofae618. Peer-reviewed.
[DOI][Pmid][serval:BIB_9C2FB806ED0B]
Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN).
Goutaudier V., Danger R., Catar R.A., Racapé M., Philippe A., Elias M., Raynaud M., Aubert O., Bouton D., Girardin F. et al., 2024/11. Kidney international, 106 (5) pp. 943-960. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1CCC1ACCEB87]
 
Toward a Clinical Decision Support System for Monitoring Therapeutic Antituberculosis Medical Drugs in Tanzania (Project TuberXpert): Protocol for an Algorithm' Development and Implementation.
Thoma Y., Cathignol A.E., Pétermann Y.J., Sariko M.L., Said B., Csajka C., Guidi M., Mpagama S.G., 2024/10/21. JMIR research protocols, 13 pp. e58720. Peer-reviewed.
[DOI][Pmid][serval:BIB_B03605089A55]
 
Ideal Time to Conduct a Pharmacokinetic Investigation After Delivery to Fully Capture the Effect of Pregnancy on Drug Exposure.
Berton M., Stader F., Bettonte S., Battegay M., Marzolini C., 2024/10. Open forum infectious diseases, 11 (10) pp. ofae585. Peer-reviewed.
[DOI][Pmid][serval:BIB_885488F32325]
 
Neurodevelopmental outcomes of infants after in utero exposure to SARS-CoV-2 or mRNA COVID-19 vaccine compared to unexposed infants: a COVI-PREG prospective cohort study
Favre Guillaume, Bromley Rebecca L., Bluett-Duncan Matthew, Maisonneuve Emeline, Pomar Léo, Daire Charlotte, Radan Anda-Petronela, Raio Luigi, Surbek Daniel, Blume Carolin et al., 2024/10. Clinical Microbiology and Infection. Peer-reviewed.
[DOI][Pmid][serval:BIB_95F7CE5CD8FE]
Novel Patient-Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use.
Dao K., Buettcher M., Golhen K., Kost J., Schittny A., Duthaler U., Atkinson A., Haefliger D., Guidi M., Bardinet C. et al., 2024/10. Journal of clinical pharmacology, 64 (10) pp. 1295-1303. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6FBF4894C204]
 
Transient secondary pseudo-hypoaldosteronism in infants with urinary tract infections: systematic literature review.
Betti C., Lavagno C., Bianchetti M.G., Kottanattu L., Lava SAG, Schera F., Lacalamita M.C., Milani G.P., 2024/10. European journal of pediatrics, 183 (10) pp. 4205-4214. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BA3676012753]
 
Drug-Related Pyroglutamic Acidosis: Systematic Literature Review.
Scafetta T., Kovacs O., Milani G.P., Bronz G., Lava SAG, Betti C., Vanoni F., Bianchetti M.G., Faré P.B., Camozzi P., 2024/09/27. Journal of clinical medicine, 13 (19). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0628E899268A]
 
Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg.
Golhen K., Buettcher M., Huwyler J., van den Anker J., Gotta V., Dao K., Rothuizen L.E., Kobylinski K., Pfister M., 2024/09/07. Pharmaceutics, 16 (9). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_28526707336D]
 
Bridging the Evidence Gap: Sotrovimab Use in Pregnancy and the Need for Comprehensive Drug Safety Data.
Winterfeld U., 2024/09. Drug safety, 47 (9) pp. 841-842. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B54F8F61AC55]
 
Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk.
Abela I.A., Chammartin F., Amstutz A., Surial B., Ballif M., Marzolini C., Aebi-Popp K., Notter J., Segeral O., Stoeckle M. et al., 2024/09. Open forum infectious diseases, 11 (9) pp. ofae502. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_40F9EA6FADDD]
Microfurnace or filament pyrolyzer: an example of pyrolysis-GC/MS for condom lubricant analysis
Burnier Céline, Maurer Jonathan, 2024/09. Forensic Chemistry, 40 p. 100593.
[URN][DOI][WoS][serval:BIB_FAFE9BBECD62]
Prevalence of actionable pharmacogenetic variants and high-risk drug prescriptions: A Swiss hospital-based cohort study.
Hodel F., De Min M.B., Thorball C.W., Redin C., Vollenweider P., Girardin F., Fellay J., 2024/09. Clinical and translational science, 17 (9) pp. e70009. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1F053E42785D]
 
Effect of Obesity on the Exposure of Long-acting Cabotegravir and Rilpivirine: A Modeling Study.
Bettonte S., Berton M., Stader F., Battegay M., Marzolini C., 2024/08/16. Clinical infectious diseases, 79 (2) pp. 477-486. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9B460E0DD4D0]
Neuropeptide Y and Derivates Are Not Ready for Prime Time in Prostate Cancer Early Detection.
Maurer J., Eugster P.J., Collins K., Vocat C., Oke J., Nicholson B., Rakauskas A., Grouzmann E., Valerio M., 2024/08. European urology open science, 66 pp. 12-15. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_803CC99B0FD9]
Prevalence and predictors of residual antibiotics in children's blood in community settings in Tanzania.
Lotto T., Renggli S., Kaale E., Masanja H., Ternon B., Décosterd L.A., D'Acremont V., Genton B., Kulinkina A.V., 2024/08. Clinical microbiology and infection, 30 (8) pp. 1042-1048. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_240D2082DE3B]
Exposures to non-therapeutic chemicals before, during and after pregnancy: data from the Swiss Teratogen Information Service (STIS).
Srikantha P., Winterfeld U., Girardin F., Panchaud A., Ochsenbein-Kölble N., Simões-Wüst A.P., 2024/07/16. Swiss medical weekly, 154 p. 3751. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1485D89DBE55]
 
Antifungal drug penetration in soft tissue abscesses: a comparative analysis.
Cancela Costa A., Kritikos A., Glampedakis E., Da Silva Pereira Clara J., Schaller F., Mercier T., Strasser R., Balmpouzis Z., Koutsokera A., Manuel O. et al., 2024/07/01. The Journal of antimicrobial chemotherapy, 79 (7) pp. 1668-1672. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_94BC817AB3D7]
 
Oritavancin use in patients with recurrent bone infections by methicillin-resistant Staphylococcus aureus with monitoring of concentrations.
Bongiovanni M., Thoueille P., Barda B., Mercier T., Marzolini C., Ramponi N., Choong E., Cantù M., Decosterd L.A., Bernasconi E., 2024/07. European journal of clinical microbiology & infectious diseases, 43 (7) pp. 1503-1504. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_798E811CC577]
Quantification of endogenous Angiotensin 1-10, 1-9, 1-8, 1-7, and 1-5 in human plasma using micro-UHPLC-MS/MS: Outlining the importance of the pre-analytics for reliable results.
Maurer J., de Groot A., Martin L., Grouzmann E., Wuerzner G., Eugster P.J., 2024/06/15. Journal of pharmaceutical and biomedical analysis, 243 p. 116101. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_581711601DE7]
 
Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study.
Ravix A., Bandiera C., Cardoso E., Lata-Pedreira A., Chtioui H., Decosterd L.A., Wagner A.D., Schneider M.P., Csajka C., Guidi M., 2024/06/11. Cancers, 16 (12). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3DC9393D4173]
 
Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study.
Audran R., Chtioui H., Thierry A.C., Mayor C.E., Vallotton L., Dao K., Rothuizen L.E., Maghraoui A., Pennella E.J., Brunner-Ferber F. et al., 2024/06/04. Scientific reports, 14 (1) p. 12872. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_728141A25F81]
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIV.
Thoueille P., Saldanha S.A., Schaller F., Choong E., Veuve F., Munting A., Cavassini M., Braun D., Günthard H.F., Duran Ramirez J.J. et al., 2024/06. Clinical pharmacology and therapeutics, 115 (6) pp. 1450-1459. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A008171B295E]
Population Pharmacokinetics in Oncology and Its Clinical Applications.
Widmer N., Guidi M., Buclin T., 2024/05/25. Pharmaceutics, 16 (6) p. 711. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7F7890B07A5F]
Development of a physiologically-based pharmacokinetic model to simulate the pharmacokinetics of intramuscular antiretroviral drugs.
Bettonte S., Berton M., Battegay M., Stader F., Marzolini C., 2024/05. CPT, 13 (5) pp. 781-794. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D188265E47AC]
Isavuconazole for the Treatment of Fungal Infections: A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS).
Couchepin J., Reinhold I., Kronig I., Guidi M., Buclin T., Schreiber P.W., Neofytos D., Lamoth F., Fungal Infection Network of Switzerland (FUNGINOS), 2024/05. Open forum infectious diseases, 11 (5) pp. ofae223. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7689B1E13106]
Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services.
Dao K., Shechtman S., Weber-Schoendorfer C., Diav-Citrin O., Murad R.H., Berlin M., Hazan A., Richardson J.L., Eleftheriou G., Rousson V. et al., 2024/04/24. BMJ open, 14 (4) pp. e083550. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AC208C4ACC61]
Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL'HIV open-label, factorial randomised controlled trial.
Marinosci A., Sculier D., Wandeler G., Yerly S., Stoeckle M., Bernasconi E., Braun D.L., Vernazza P., Cavassini M., Buzzi M. et al., 2024/04/15. Swiss medical weekly, 154 p. 3762. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_3E0EFC449AF1]
Acute ischaemic stroke in active cancer versus non-cancer patients: stroke characteristics, mechanisms and clinical outcomes.
Costamagna G., Hottinger A.F., Milionis H., Salerno A., Strambo D., Livio F., Navi B.B., Michel P., 2024/04. European journal of neurology, 31 (4) pp. e16200. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_33F6C6BB2CCE]
Drug Exposure of Long-Acting Cabotegravir and Rilpivirine in Older People With Human Immunodeficiency Virus: A Pharmacokinetic Modeling Study.
Bettonte S., Berton M., Stader F., Battegay M., Marzolini C., 2024/04. Open forum infectious diseases, 11 (4) pp. ofae171. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D14B6E2F8C73]
Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An update.
Briki M., Murisier A., Guidi M., Seydoux C., Buclin T., Marzolini C., Girardin F.R., Thoma Y., Carrara S., Choong E. et al., 2024/04/01. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1236 p. 124039. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CC804B352E24]
Population pharmacokinetic analysis of doravirine in real-world people with HIV.
Thoueille P., Delarive L., Cavassini M., Buclin T., Decosterd L.A., Marzolini C., Girardin F.R., Guidi M., Swiss HIV Cohort Study, 2024/04. British journal of clinical pharmacology, 90 (4) pp. 1058-1065. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0E37EFB8FE58]
Improving Data Collection in Pregnancy Safety Studies: Towards Standardisation of Data Elements in Pregnancy Reports from Public and Private Partners, A Contribution from the ConcePTION Project.
Favre G., Richardson J.L., Moore A., Geissbühler Y., Jehl V., Oliver A., Shechtman S., Diav-Citrin O., Berlin M., De Haan T. et al., 2024/03. Drug safety, 47 (3) pp. 227-236. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C5487C3C03C0]
Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study.
Ambrosioni J., Díaz N.A., Marzolini C., Dragovic G., Imaz A., Calcagno A., Luque S., Curran A., Troya J., Tuset M. et al., 2024/03. Infectious diseases and therapy, 13 (3) pp. 609-617. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0F13E410DA20]
Validation of a Novel Method to Assess the Clinical Quality of Information in Pregnancy-Related Pharmacovigilance Case Reports: A ConcePTION Project.
van Rijt-Weetink YRJ, Egberts TCG, van Hunsel FPAM, Lewis D.J., Yates L.M., Winterfeld U., van Puijenbroek E.P., 2024/03. Drug safety, 47 (3) pp. 261-270. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D5412B03225D]
Guidance for the Interpretation of Long-Acting Cabotegravir and Rilpivirine Concentrations Based on Real-World Therapeutic Drug Monitoring Data and Documented Failures.
Thoueille P., Cavassini M., Guidi M., Buclin T., Girardin F.R., Decosterd L.A., Marzolini C., 2024/02. Open forum infectious diseases, 11 (2) pp. ofae023. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E70DD8E56C37]
The Deleterious Consequences of a Nonsteroidal Anti-inflammatory Drug in an Eisenmenger Patient.
Grütter S., Haefliger D., Wuerzner G., Yerly P., Bouchardy J., Rutz T., 2024/02. CJC pediatric and congenital heart disease, 3 (1) pp. 11-13. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8124EBF0DD1D]
Contrast-enhanced ultrasonography reveals a lower cortical perfusion and a decreased renal flow reserve in hypertensive patients.
Damianaki A., Hendriks-Balk M., Brito W., Polychronopoulou E., Theiler K., Maillard M., Maurer J., Eugster P., Pruijm M., Wuerzner G., 2024/01/31. Nephrology, dialysis, transplantation, 39 (2) pp. 242-250. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_FE31072D46DB]
Antiretroviral Drug Exposure and Response in Obese and Morbidly Obese People With Human Immunodeficiency Virus (HIV): A Study Combining Modelling and Swiss HIV Cohort Data.
Berton M., Bettonte S., Stader F., Decosterd L., Tarr P.E., Livio F., Cavassini M., Braun D.L., Kusejko K., Hachfeld A. et al., 2024/01/25. Clinical infectious diseases, 78 (1) pp. 98-110. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CE2036172D19]
 
Pharmacovigilance. Sevrage et effet rebond: pas seulement avec les psychotropes [Pharmacovigilance. Withdrawal and rebound effects: not just with psychotropic drugs]
Marouf R., Chtioui H., Girardin F.R., Buclin T., Diezi L., 2024/01/17. Revue medicale suisse, 20 (856-7) pp. 96-101. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_22BF36045EE8]
Drug- and Toxin-Induced Opsoclonus - a Systematized Review, including a Case Report on Amantadine-Induced Opsoclonus in Multiple System Atrophy.
Cannilla H., Messe M., Girardin F., Borruat F.X., Bally J.F., 2024. Tremor and other hyperkinetic movements, 14 p. 23. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_44877DB662EE]
Hypertension in a Patient With Polycystic Kidney Disease Complicated by Concomitant Pheochromocytoma.
Ameti A., Kopp P.A., Pitteloud N., Wuerzner G., Grouzmann E., Matter M., Lamine F., Phan O., 2024. AACE clinical case reports, 10 (4) pp. 136-139. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7B764FF92092]
Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland.
Thoueille P., Saldanha S.A., Schaller F., Choong E., Munting A., Cavassini M., Braun D., Günthard H.F., Kusejko K., Surial B. et al., 2024/01. The Lancet regional health. Europe, 36 p. 100793. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_EE4919775F0F]
Vancomycin Dosing Strategy for the Treatment of Peritonitis in a Child on Automated Peritoneal Dialysis: A First Pediatric Case Report.
Haefliger D., Chehade H., Livio F., Rodrigues-Veiga V., Diezi L., Marzolini C., 2024. Seminars in dialysis, 37 (6) pp. 461-465. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_31FDA1A2A806]
2023
5-Fluorouracil-associated severe hypertriglyceridaemia with positive rechallenge.
Giacomuzzi Moore B., Durigova A., Lamine F., Chtioui H., Salati E., 2023/12/19. BMJ case reports, 16 (12). Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_E970BBCD043C]
Effects of maternal modafinil treatment on fetal development and neonatal growth parameters - a multicenter case series of the European Network of Teratology Information Services (ENTIS).
Onken M., Lohse L., Coulm B., Beghin D., Richardson J.L., Bermejo-Sánchez E., Aguilera C., Bosch M., Cassina M., Chouchana L. et al., 2023/12/18. Acta psychiatrica Scandinavica. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B40779556255]
Antidepressants and the risk of bleeding in the era of anti-amyloid drugs.
Pozuelo Moyano B., Salvioni P., Zullo L., Rouaud O., von Gunten A., Girardin F.R., Allali G., 2023/12. Alzheimer's & dementia, 19 (12) pp. 5847-5848. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B8B8E3A8AB5C]
Intramuscular cabotegravir and rilpivirine concentrations after switching from efavirenz-containing regimen.
Bettonte S., Berton M., Stader F., Battegay M., Marzolini C., 2023/12. British journal of clinical pharmacology, 89 (12) pp. 3618-3628. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_248B4D9C065B]
 
Therapeutic drug monitoring of TB drugs
Choong Eva, Marzolini Catia, Girardin François, Decosterd Laurent, Köhler Niklas, 2023/12. dans Translational TB-Forum, Inselspital Bern, December 11, 2023. Peer-reviewed.
[serval:BIB_71F805AD727A]
Pregnancy outcomes after GLP-1 agonist exposure in early pregnancy
Winterfeld Ursula, Dao Kim, Haefliger David, Diezi Léonore, Girardin François, 2023/11/23. Swissmedic Vigilance News. Peer-reviewed.
[URN][serval:BIB_9BF96D812CDD]
Development and validation of a multiplex HPLC-MS/MS assay for the monitoring of JAK inhibitors in patient plasma.
Tachet J., Versace F., Mercier T., Buclin T., Decosterd L.A., Choong E., Girardin F.R., 2023/11/15. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1230 p. 123917. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_670CB2162D89]
Joint fluid concentrations of amphotericin B after local application with calcium sulphate-report of 2 cases.
Pozzi L., Schläppi M., Livio F., Blatter S., Achermann Y., Wahl P., 2023/11. APMIS, 131 (11) pp. 567-573. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1F0B7B1DD6C4]
Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023.
Ambrosioni J., Levi L., Alagaratnam J., Van Bremen K., Mastrangelo A., Waalewijn H., Molina J.M., Guaraldi G., Winston A., Boesecke C. et al., 2023/11. HIV medicine, 24 (11) pp. 1126-1136. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2C3981328BD1]
A Single-Run HPLC-MS Multiplex Assay for Therapeutic Drug Monitoring of Relevant First- and Second-Line Antibiotics in the Treatment of Drug-Resistant Tuberculosis.
Köhler N., Karaköse H., Grobbel H.P., Hillemann D., Andres S., König C., Kalsdorf B., Brehm T.T., Böttcher L., Friesen I. et al., 2023/10/27. Pharmaceutics, 15 (11) p. 2543. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_549037B081C5]
 
Évaluation des risques liés aux médicaments pendant l’allaitement [Risk assessment of drugs during breastfeeding]
Cardoso E., Monfort A., Ferreira E., Fischer Fumeaux C.J., Henriot I., Winterfeld U., Gandia P., Guidi M., Panchaud A., 2023/10/18. Revue medicale suisse, 19 (846) pp. 1940-1947. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_709A7C64E9D4]
Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT study.
Gaspar F., Terrier J., Favre S., Gosselin P., Fontana P., Daali Y., Lenoir C., Samer C.F., Rollason V., Reny J.L. et al., 2023/10. CPT, 12 (10) pp. 1541-1552. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2BD727D8058F]
Risk of congenital malformation after first trimester mRNA COVID-19 vaccine exposure in pregnancy: the COVI-PREG prospective cohort.
Favre G., Maisonneuve E., Pomar L., Daire C., Monod C., Martinez de Tejada B., Quibel T., Todesco-Bernasconi M., Sentilhes L., Blume C. et al., 2023/10. Clinical microbiology and infection, 29 (10) pp. 1306-1312. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_64F80190B0CC]
Population pharmacokinetic analysis of lopinavir in HIV negative individuals exposed to SARS-CoV-2: a COPEP (COronavirus Post-Exposure Prophylaxis) sub-study.
Thoueille P., Delfraysse M., Andre P., Buclin T., Decosterd L.A., Fedeli C., Ustero P., Calmy A., Guidi M., Swiss HIV Cohort Study, 2023/09/27. BMC pharmacology & toxicology, 24 (1) p. 47. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0252DE874823]
Cost-effectiveness of Hepatocellular Carcinoma Surveillance Strategies in Switzerland
Goossens Nicolas, Garay Osvaldo Ulises, Wolf Cyrill, Ambühl Louisa Elena, Kugler Vanessa, Girardin François, 2023/09/11., Annual Meeting of the Swiss Society of Gastroenterology (SGG-SSG), the Swiss Society of Visceral Surgery (SGVC-SSCV), the Swiss Association for the Study of the Liver (SASL) and the Swiss Society of Endoscopy Nurses and Associates (SVEP-ASPE), 14-15 September pp. 6S dans Swiss Medical Weekly.
[URN][WoS][serval:BIB_3C9E2B550ECB]
Supplementum 272: Abstracts of the Annual meeting of the Swiss Society of Gastroenterology, the Swiss Society of Visceral Surgery, the Swiss Association for the Study of the Liver and the Swiss Society of Endoscopy Nurses and Associates
Juillerat Pascal, Tachet Jérémie, Mercier Thomas, Versace François, Guidi Monia, Buclin Thierry, Decosterd Laurent, Choong Eva, Girardin François, 2023/09/11., Annual meeting of the Swiss Society of Gastroenterology , the Swiss Society of Visceral Surgery, the Swiss Association for the Study of the Liver, the Swiss Society of Endoscopy Nurses and Associates pp. s3511 dans Swiss Medical Weekly, François. Peer-reviewed, SMW Supporting Association.
[URN][DOI][Pmid][serval:BIB_478A7CAB2010]
CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (<sup>123/131</sup>I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumors.
Grand-Guillaume J., Mansi R., Gaonkar R.H., Zanger S., Fani M., Eugster P.J., Beck Popovic M., Grouzmann E., Abid K., 2023/09/07. Journal of translational medicine, 21 (1) p. 604. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9B802C61B336]
Elevated liver function tests in a patient with breast cancer.
Neftel C., Zaman K., Chtioui H., Moradpour D., Sempoux C., Fraga M., 2023/09. Journal of hepatology, 79 (3) pp. e109-e111. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E70D878557D9]
Tutorial review for peptide assays: An ounce of pre-analytics is worth a pound of cure.
Maurer J., Grouzmann E., Eugster P.J., 2023/09/01. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1229 p. 123904. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BAE163499AE3]
Modeling tumor size dynamics based on real-world electronic health records and image data in advanced melanoma patients receiving immunotherapy.
Courlet P., Abler D., Guidi M., Girard P., Amato F., Vietti Violi N., Dietz M., Guignard N., Wicky A., Latifyan S. et al., 2023/08. CPT, 12 (8) pp. 1170-1181. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A319336A78BD]
 
A Highly Sensitive HPLC-MS/MS MethodFor Multiplex Analysis Of Janus KinaseInhibitors In Plasma
Tachet J., Mercier T., André P., Guidi M., Buclin T., Decosterd L., Choong E., Girardin F., 2023/07. dans 19th World Congress of Basic and Clinical Pharmacology (WCP), Glasgow, July 2023.
[serval:BIB_D39D174AB865]
Clinically relevant bidirectional drug-drug interaction between midostaurin and voriconazole.
Haefliger D., Marzolini C., Lamoth F., Pabst T., Buclin T., Livio F., 2023/07. British journal of clinical pharmacology, 89 (7) pp. 2304-2308. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9BC838D4B328]
Impact of Obesity on the Drug-Drug Interaction Between Dolutegravir and Rifampicin or Any Other Strong Inducers.
Berton M., Bettonte S., Stader F., Battegay M., Marzolini C., 2023/07. Open forum infectious diseases, 10 (7) pp. ofad361. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7B67BF5F2315]
Management of Drug Interactions with Inducers: Onset and Disappearance of Induction on Cytochrome P450 3A4 and Uridine Diphosphate Glucuronosyltransferase 1A1 Substrates.
Bettonte S., Berton M., Stader F., Battegay M., Marzolini C., 2023/07. European journal of drug metabolism and pharmacokinetics, 48 (4) pp. 353-362. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_23ECE0BDE9E6]
Elements to assess the quality of information of case reports in pregnancy pharmacovigilance data—a ConcePTION project
van Rijt-Weetink Yrea R. J., Chamani Khoezik, Egberts Antoine C. G., van Hunsel Florence P. A. M., Lewis David J., Yates Laura M., Winterfeld Ursula, van Puijenbroek Eugène P., 2023/06/29. Frontiers in Drug Safety and Regulation, 3.
[URN][DOI][serval:BIB_AD667E3033F6]
 
Clinical and Demographic Characteristics, Mechanisms, and Outcomes in Patients With Acute Ischemic Stroke and Newly Diagnosed or Known Active Cancer.
Costamagna G., Hottinger A., Milionis H., Lambrou D., Salerno A., Strambo D., Livio F., Navi B.B., Michel P., 2023/06/13. Neurology, 100 (24) pp. e2477-e2489. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0F3BF5CF7627]
Four cases of audio-vestibular disorders related to immunisation with SARS-CoV-2 mRNA vaccines.
Ekobena P., Rothuizen L.E., Bedussi F., Guilcher P., Meylan S., Ceschi A., Girardin F., Dao K., 2023/06. International journal of audiology, 62 (6) pp. 587-591. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2ACA564D1A62]
Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration.
Thoueille P., Alves Saldanha S., Desfontaine V., Kusejko K., Courlet P., Andre P., Cavassini M., Decosterd L.A., Buclin T., Guidi M. et al., 2023/06/01. The Journal of antimicrobial chemotherapy, 78 (6) pp. 1433-1443. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_449BF24E5A20]
 
Simultaneous kinetics of oral vorinostat in plasma and cerebrospinal fluid in a patient with cutaneous T-cell lymphoma with CNS involvement.
Papadopoulou V., Degrauwe N., Decosterd L.A., Buclin T., Cairoli A., 2023/06. International journal of clinical pharmacology and therapeutics, 61 (6) pp. 270-272. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CC53A672C07F]
 
The road to reliable peptide assays is paved with good guidelines.
Maurer J., Grouzmann E., Eugster P.J., 2023/06. Clinical endocrinology, 98 (6) pp. 832-833. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E813FD502502]
Ibrutinib and venetoclax associated with progressive multifocal leukoencephalopathy
Haefliger David, Girardin François, 2023/05/30. Swissmedic Vigilance News. Peer-reviewed.
[URN][serval:BIB_7D819B42B9D4]
JAK inhibitors: need for dosage individualisation?
Tachet Jérémie, Girardin François, 2023/05/30. Swissmedic Vigilance News . Peer-reviewed.
[URN][serval:BIB_E5B14375BECF]
 
A highly sensitive HPLC-MS/MS method for multiplex analysis of janus kinase inhibitors in plasma
Tachet Jérémie, André Pascal, Guidi Monia, Buclin Thierry, Decosterd Laurent Arthur, Choong Eva, Girardin François, 2023/05/10. dans Congrès SSMIG 2023 - 10 au 12 mai 2023.
[serval:BIB_449F9C0F20F5]
Switch from a ritonavir to a cobicistat containing antiretroviral regimen and impact on tacrolimus levels in a kidney transplant recipient.
Erba A., Marzolini C., Rentsch K., Stoeckle M., Battegay M., Mayr M., Weisser M., 2023/05/05. Virology journal, 20 (1) p. 89. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1C2D4CA1C276]
 
Utilité du TDM des anti-rétroviraux: passé, présent, futur
Choong Eva, Thoueille Paul, Cavassini M., Decosterd Laurent, 2023/05/04. dans Association pour la ormation en Analyses de Biologie Spécialisée (AFABS) - Journée de formation du 4 mai 2023 - Lausanne . Peer-reviewed.
[serval:BIB_D453D7DC90C4]
Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION Project.
Richardson J.L., Moore A., Bromley R.L., Stellfeld M., Geissbühler Y., Bluett-Duncan M., Winterfeld U., Favre G., Alexe A., Oliver A.M. et al., 2023/05. Drug safety, 46 (5) pp. 479-491. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_91D9C2A1EBD8]
 
COVID-19-related medicine utilization study in pregnancy: The COVI-PREG cohort.
Favre G., Gerbier E., Maisonneuve E., Pomar L., Winterfeld U., Lepigeon K., Bloemenkamp KWM, de Bruin O., Eimir H., Nordeng H. et al., 2023/05. British journal of clinical pharmacology, 89 (5) pp. 1560-1574. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B0F93E870352]
Pretomanid-resistant tuberculosis.
Koehler N., Andres S., Merker M., Dreyer V., John A., Kuhns M., Krieger D., Choong E., Verougstraete N., Zur Wiesch P.A. et al., 2023/05. The Journal of infection, 86 (5) pp. 520-524. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_07AF0EE6CA11]
Semiautomated Pipeline to Quantify Tumor Evolution From Real-World Positron Emission Tomography/Computed Tomography Imaging.
Abler D., Courlet P., Dietz M., Gatta R., Girard P., Munafo A., Wicky A., Jreige M., Guidi M., Latifyan S. et al., 2023/05. JCO clinical cancer informatics, 7 pp. e2200126. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D61806C1E839]
Determinants of Vaccination and Willingness to Vaccinate against COVID-19 among Pregnant and Postpartum Women during the Third Wave of the Pandemic: A European Multinational Cross-Sectional Survey.
Maisonneuve E., Gerbier E., Tauqeer F., Pomar L., Favre G., Winterfeld U., Passier A., Oliver A., Baud D., Nordeng H. et al., 2023/04/29. Viruses, 15 (5) p. 1090. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_90BC43AA1255]
Management of Drug-Drug Interactions Between Long-Acting Cabotegravir and Rilpivirine and Comedications With Inducing Properties: A Modeling Study.
Bettonte S., Berton M., Stader F., Battegay M., Marzolini C., 2023/04/03. Clinical infectious diseases, 76 (7) pp. 1225-1236. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E90B3808E4B0]
Counter-regulatory responses to postprandial hypoglycaemia in patients with post-bariatric hypoglycaemia vs surgical and non-surgical control individuals.
Tripyla A., Herzig D., Reverter-Branchat G., Pavan J., Schiavon M., Eugster P.J., Grouzmann E., Nakas C.T., Sauvinet V., Meiller L. et al., 2023/04. Diabetologia, 66 (4) pp. 741-753. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1ADF058AB47C]
 
Interest of therapeutic drug monitoring: lumacaftor, ivacaftor, tezacaftor, and elexacaftor.
Choong Eva, Sauty A., Koutsokera A., Blanchon S., André Pascal, Decosterd L., 2023/03. dans Journée mucoviscidose romande March 2023 - Lausanne. Peer-reviewed.
[serval:BIB_27E71891505C]
Maternal and perinatal outcomes following pre-Delta, Delta, and Omicron SARS-CoV-2 variants infection among unvaccinated pregnant women in France and Switzerland: a prospective cohort study using the COVI-PREG registry.
Favre G., Maisonneuve E., Pomar L., Daire C., Poncelet C., Quibel T., Monod C., Martinez de Tejada B., Schäffer L., Papadia A. et al., 2023/03. The Lancet regional health. Europe, 26 p. 100569. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B8F54B585016]
Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies.
Biniecka P., Matsumoto S., Belotti A., Joussot J., Bai J.F., Majjigapu S.R., Thoueille P., Spaggiari D., Desfontaine V., Piacente F. et al., 2023/02/16. Molecules, 28 (4) p. 1897. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9D877CB69A0A]
An innovative ethosuximide granule formulation designed for pediatric use: Comparative pharmacokinetics, safety, tolerability, and palatability profile versus reference syrup.
Diezi L., Dao K., Jullien V., Roussel-Maupetit C., Burton I., André P., Bardinet C., Rothuizen L.E., Chtioui H., Manso-Silvan M.A. et al., 2023/02. Pharmacology research & perspectives, 11 (1) pp. e01032. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8A3E445B0338]
Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs.
Overbeek J.K., Heine R.T., Verheul HMW, Chatelut E., Rudek M.A., Gurney H., Plummer R., Gilbert D.C., Buclin T., Burger D.M. et al., 2023/02. ESMO open, 8 (1) p. 100749. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B9A4F5D5E104]
Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals.
Berton M., Bettonte S., Stader F., Battegay M., Marzolini C., 2023/02. Clinical pharmacokinetics, 62 (2) pp. 277-295. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D73E02992F11]
Pharmacothérapie. Nouveaux médicaments et vaccins disponibles en 2022 [Pharmacotherapy. New drugs and vaccines in 2022]
Haefliger D., Livio F., 2023/01/18. Revue medicale suisse, 19 (N° 809-10) pp. 66-73. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_E288C6961945]
Optimized LC-MS/MS quantification of tuberculosis drug candidate macozinone (PBTZ169), its dearomatized Meisenheimer Complex and other metabolites, in human plasma and urine.
Desfontaine V., Guinchard S., Marques S., Vocat A., Moulfi F., Versace F., Huser-Pitteloud J., Ivanyuk A., Bardinet C., Makarov V. et al., 2023/01/15. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1215 p. 123555. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_405A2D6AF487]
Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study.
Bandiera C., Locatelli I., Courlet P., Cardoso E., Zaman K., Stravodimou A., Dolcan A., Sarivalasis A., Zurcher J.P., Aedo-Lopez V. et al., 2023/01/03. Cancers, 15 (1) p. 316. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2263B25B85EB]
 
An interprofessional medication adherence program to optimize adherence to oral anticancer therapies: a randomized-controlled trial
Bandiera C., Cardoso E., Locatelli I., Digklia A., Zaman K., Diciolla A., Cristina V., Stravodimou A., Lopez V.A., Dolcan A. et al., 2023., 26th International Society for Medication Adherence (ESPACOMP) Conference p. 269 dans International Journal of Clinical Pharmacy. Peer-reviewed.
[DOI][Pmid][serval:BIB_944A7B3041CF]
Antidiabetic Medication Utilisation before and during Pregnancy in Switzerland between 2012 and 2019: An Administrative Claim Database from the MAMA Cohort.
Gerbier E., Favre G., Maisonneuve E., Ceulemans M., Winterfeld U., Dao K., Schmid CPR, Jenkinson S.P., Niznik B., Baud D. et al., 2023. Journal of diabetes research, 2023 p. 4105993. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8E93F01323A7]
Development and validation of a liquid chromatography coupled to tandem mass spectrometry method for the monitoring of temsavir plasma concentrations in people living with HIV.
Thoueille P., Seybold U., Decosterd L.A., Desfontaine V., 2023/01/01. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1214 p. 123575. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0B73DC88085D]
Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment.
Girardin F.R., Cohen K., Schwenkglenks M., Durand-Zaleski I., 2023. Frontiers in pharmacology, 14 p. 1210002. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1C74847FFDC9]
Estimating glomerular filtration rate from serum creatinine concentration in children with augmented renal clearance: all formulas are equivocal, but some are more equivocal than others.
André P., Chtioui H., Dao K., Rothuizen L.E., Di Paolo E.R., Diezi M., Crisinel P.A., Cachat F., Chehade H., Buclin T., 2023/01. Kidney international, 103 (1) pp. 225-226. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E06602D511F4]
From personalized to precision medicine in oncology: A model-based dosing approach to optimize achievement of imatinib target exposure.
Goutelle S., Guidi M., Gotta V., Csajka C., Buclin T., Widmer N., 2023. Pharmaceutics, 15 (4) p. 1081. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_829AAAA406A8]
Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN).
Girardin F.R., Nicolet A., Bestard O., Lefaucheur C., Budde K., Halleck F., Brouard S., Giral M., Gourraud P.A., Horcholle B. et al., 2023. Frontiers in pharmacology, 14 p. 1040584. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E5F96D1F8644]
Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project.
Monfort A., Cardoso E., Eap C.B., Fischer Fumeaux C.J., Graz M.B., Morisod Harari M., Weisskopf E., Gandia P., Allegaert K., Nordeng H. et al., 2023. Frontiers in psychiatry, 14 p. 1167870. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EE8A9936EA15]
Major malformations risk following early pregnancy exposure to metformin: a systematic review and meta-analysis.
Abolhassani N., Winterfeld U., Kaplan Y.C., Jaques C., Minder Wyssmann B., Del Giovane C., Panchaud A., 2023/01. BMJ open diabetes research & care, 11 (1) pp. e002919. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_09E70EA3988A]
 
Maternal drugs and breastfeeding: Risk assessment from pharmacokinetics to safety evidence - A contribution from the ConcePTION project.
Cardoso E., Monfort A., Ferreira E., Nordeng H., Winterfeld U., Allegaert K., Gandia P., Guidi M., Panchaud A., 2023. Therapie, 78 (2) pp. 149-156. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_616A71B2E82E]
Precision oncology by point-of-care therapeutic drug monitoring and dosage adjustment of conventional cytotoxic chemotherapies: A perspective.
Briki M., André P., Thoma Y., Widmer N., Wagner A.D., Decosterd L.A., Buclin T., Guidi M., Carrara S., 2023. Pharmaceutics, 15 (4) p. 1283. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A82A8DDE8796]
Reproductive Safety of Trazodone After Maternal Exposure in Early Pregnancy: A Comparative ENTIS Cohort Study.
Dao K., Shechtman S., Diav-Citrin O., George N., Richardson J.L., Rollason V., Pistelli A., Eleftheriou G., Berlin M., Ekobena P. et al., 2023. Journal of clinical psychopharmacology, 43 (1) pp. 12-19. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_009EB5838B3E]
 
Safety of medicines during breastfeeding - from case report to modeling: a contribution from the ConcePTION project.
Cardoso E., Guidi M., Nauwelaerts N., Nordeng H., Teil M., Allegaert K., Smits A., Gandia P., Edginton A., Ito S. et al., 2023. Expert opinion on drug metabolism & toxicology, 19 (5) pp. 269-283. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FDFE0C5041A6]
 
What is the significance of the pharmacokinetic profile and potential drug-drug interactions of long-acting intramuscular cabotegravir and rilpivirine?
Bettonte S., Berton M., Marzolini C., 2023. Expert opinion on drug metabolism & toxicology, 19 (5) pp. 243-247. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FA8BB1B82639]
2022
Population pharmacokinetic analyses of regorafenib and capecitabine in patients with locally advanced rectal cancer (SAKK 41/16 RECAP).
Schmulenson E., Bovet C., Theurillat R., Decosterd L.A., Largiadèr C.R., Prost J.C., Csajka C., Bärtschi D., Guckenberger M., von Moos R. et al., 2022/12. British journal of clinical pharmacology, 88 (12) pp. 5336-5347. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FD41EC93A336]
Saxagliptin: A potential doping agent? A randomized, double-blinded, placebo-controlled, and crossover pilot study in young active men.
Bourdillon N., Eugster P.J., Vocat C., Nguyen T., Wuerzner G., Grouzmann E., Millet G.P., 2022/12. Physiological reports, 10 (23) pp. e15515. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_23C966666087]
Treatment-emergent adverse events and antiseizure medication actual drug load.
Prétat T., Aícua-Rapún I., André P., Lebon S., Rossetti A.O., Decosterd L.A., Buclin T., Novy J., 2022/12. Epilepsy & behavior, 137 (Pt A) p. 108980. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7D05EB7BE2F8]
Transfer of antiretroviral drugs into breastmilk: a prospective study from the Swiss Mother and Child HIV Cohort Study.
Aebi-Popp K., Kahlert C.R., Crisinel P.A., Decosterd L., Saldanha S.A., Hoesli I., Martinez De Tejada B., Duppenthaler A., Rauch A., Marzolini C. et al., 2022/11/28. The Journal of antimicrobial chemotherapy, 77 (12) pp. 3436-3442. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_86A7D946ED7E]
 
A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis.
Mercier T., Desfontaine V., Cruchon S., Da Silva Pereira Clara J.A., Briki M., Mazza-Stalder J., Kajkus A., Burger R., Suttels V., Buclin T. et al., 2022/11/15. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1211 p. 123456. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8BD27ECE6B02]
 
Corrigendum to "Validation and clinical application of a multiplex high performance liquid chromatography - Tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections" [J. Chromatogr. B 1157 (2020) 122160].
Decosterd L.A., Mercier T., Ternon B., Cruchon S., Guignard N., Lahrichi S., Pesse B., Rochat B., Burger R., Lamoth F. et al., 2022/11/15..
[DOI][WoS][Pmid][serval:BIB_D81DA54DDABE]
Mental health in pregnant individuals during the COVID-19 pandemic based on a Swiss online survey.
Favre G., Kunz C., Schwank S., Chung H.F., Radan A.P., Raio L., Fluri M., Winterfeld U., Baud D., Pomar L., 2022/11/02. Scientific reports, 12 (1) p. 18448. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A062437FE5CF]
Wound fluid ceftriaxone concentrations after local application with calcium sulphate as carrier material in the treatment of orthopaedic device-associated hip infections.
Wiesli M.G., Livio F., Achermann Y., Gautier E., Wahl P., 2022/11. Bone & joint research, 11 (11) pp. 835-842. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_532092A187FF]
Inhibiteurs des Janus kinases : nouvelles perspectives pour la médecine de précision ? [Janus kinase inhibitors : new perspectives for precision medicine ?]
Tachet J., Dumusc A., Conrad C., Grandoni F., Chalandon Y., Ribi C., Buclin T., Girardin F., 2022/10/19. Revue medicale suisse, 18 (800) pp. 1979-1983. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0D12F79D0C49]
Implementation and Cross-Validation of a Pharmacokinetic Model for Precision Dosing of Busulfan in Hematopoietic Stem Cell Transplanted Children.
Goutelle S., Thoma Y., Buffet R., Philippe M., Buclin T., Guidi M., Csajka C., 2022/10/01. Pharmaceutics, 14 (10) p. 2107. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1F77B194CA9D]
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events.
Coukos A., Vionnet J., Obeid M., Bouchaab H., Peters S., Latifyan S., Wicky A., Michielin O., Chtioui H., Moradpour D. et al., 2022/10. Journal for immunotherapy of cancer, 10 (10) pp. e005635. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F836C2B098EA]
Collaborative Challenges of Multi-Cohort Projects in Pharmacogenetics-Why Time Is Essential for Meaningful Collaborations.
Franchini F., Kusejko K., Marzolini C., Tellenbach C., Rossi S., Stampf S., Koller M., Stoyanov J., Möller B., Leichtle A.B., 2022/09/29. JMIR formative research, 6 (9) pp. e36759. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_45A10307821C]
 
Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer.
Rodier T., Puszkiel A., Cardoso E., Balakirouchenane D., Narjoz C., Arrondeau J., Fallet V., Khoudour N., Guidi M., Vidal M. et al., 2022/09/01. Pharmaceutics, 14 (9) p. 1844. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_72EF703BC03A]
 
Hepatitis B reactivation during ruxolitinib treatment.
Sjoblom M., Chtioui H., Fraga M., Stalder G., Grandoni F., Blum S., 2022/09. Annals of hematology, 101 (9) pp. 2081-2086. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_97208521780E]
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021.
Ryom L., De Miguel R., Cotter A.G., Podlekareva D., Beguelin C., Waalewijn H., Arribas J.R., Mallon PWG, Marzolini C., Kirk O. et al., 2022/09. HIV medicine, 23 (8) pp. 849-858. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_63D4B2B09234]
Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma.
Eugster P.J., Maurer J., Vocat C., Abid K., Matter M., Wuerzner G., Trepp R., Fischli S., Henzen C., Kolb W. et al., 2022/09/01. Clinica chimica acta; international journal of clinical chemistry, 534 pp. 146-155. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_569E60EE2BE0]
 
Queries on medication use during pregnancy: An analysis of data from the Swiss Teratogen Information Service
Baumgartner R., Winterfeld U., Panchaud A., Simoes-Wüst A.P., 2022/09., ENTIS 33rd Conference dans Neurotoxicology and Teratology.
[WoS][serval:BIB_38F7C472A8F3]
Repository Describing the Anatomical, Physiological, and Biological Changes in an Obese Population to Inform Physiologically Based Pharmacokinetic Models.
Berton M., Bettonte S., Stader F., Battegay M., Marzolini C., 2022/09. Clinical pharmacokinetics, 61 (9) pp. 1251-1270. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3C20802AF175]
Valproate in status epilepticus: Correlation between loading dose, serum levels, and clinical response.
Vijiala S., André P., Buclin T., Decosterd L.A., Rossetti A.O., Novy J., 2022/09. European journal of neurology, 29 (9) pp. 2607-2611. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_729D01C11191]
Métabolisme et suivi thérapeutique de l’azathioprine en gastroentérologie et hépatologie [Metabolism and therapeutic monitoring of azathioprine in gastroenterology and hepatology]
Bianchetti D., Salvador Nunes L., André P., Schoepfer A., Moradpour D., Chtioui H., 2022/08/31. Revue medicale suisse, 18 (793) pp. 1588-1593. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8BF7916B0E8B]
Therapeutic Drug Monitoring of Ivacaftor, Lumacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis: Where Are We Now?
Choong E., Sauty A., Koutsokera A., Blanchon S., André P., Decosterd L., 2022/08/11. Pharmaceutics, 14 (8) p. 1674. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0CAC2AC96B31]
Quantification of serotonin and eight of its metabolites in plasma of healthy volunteers by mass spectrometry.
Eugster P.J., Dunand M., Grund B., Ivanyuk A., Fogarasi Szabo N., Bardinet C., Abid K., Buclin T., Grouzmann E., Chtioui H., 2022/08/10. Clinica chimica acta; international journal of clinical chemistry, 535 pp. 19-26. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7C0E1266F726]
Comment to "Pregnancy and COVID-19, focus on vaccine and pharmacological treatment".
Ceulemans M., Sillis L., Foulon V., Panchaud A., Winterfeld U., Pomar L., Cleary B., O'Shaughnessy F., Passier A., Richardson J.L. et al., 2022/08. Journal of reproductive immunology, 152 p. 103639. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6CA029225212]
 
Evaluating the risk of drug-drug interactions with pharmacokinetic boosters: the case of ritonavir-enhanced nirmatrelvir to prevent severe COVID-19.
Girardin F., Manuel O., Marzolini C., Buclin T., 2022/08. Clinical microbiology and infection, 28 (8) pp. 1044-1046. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_30CD844F1841]
Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure Simulation.
Terrier J., Gaspar F., Guidi M., Fontana P., Daali Y., Csajka C., Reny J.L., 2022/08. Clinical pharmacology and therapeutics, 112 (2) pp. 353-363. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2F23BCB64F8E]
Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland.
Thoueille P., Alves Saldanha S., Schaller F., Munting A., Cavassini M., Braun D., Günthard H.F., Kusejko K., Surial B., Furrer H. et al., 2022/07/29. Pharmaceutics, 14 (8) p. 1588. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EA4A25E4F31E]
COVID-19 mRNA vaccine in pregnancy: Results of the Swiss COVI-PREG registry, an observational prospective cohort study.
Favre G., Maisonneuve E., Pomar L., Winterfeld U., Daire C., Martinez de Tejada B., Delecraz D., Campelo S., Moser M., Todesco-Bernasconi M. et al., 2022/07. The Lancet regional health. Europe, 18 p. 100410. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_274FE2B56EDF]
Enantiospecific pharmacokinetics of intravenous dexmedetomidine in beagles.
Levionnois O.L., Barbarossa A., Bardhi A., Siegenthaler J., Forss Pleyers T., Guidi M., Spadavecchia C., Raillard M., 2022/07. Journal of veterinary pharmacology and therapeutics, 45 (4) pp. 366-372. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F2C44CF39F4A]
Practical recommendations to combine small-molecule inhibitors and direct oral anticoagulants in patients with nonsmall cell lung cancer.
Otten L.S., Piet B., van den Heuvel M.M., Marzolini C., van Geel RMJM, Gulikers J.L., Burger D.M., Leentjens J., Ter Heine R., 2022/06/30. European respiratory review, 31 (164). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_947C3642CB1E]
Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer.
Courlet P., Cardoso E., Bandiera C., Stravodimou A., Zurcher J.P., Chtioui H., Locatelli I., Decosterd L.A., Darnaud L., Blanchet B. et al., 2022/06/21. Pharmaceutics, 14 (7) p. 1317. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E7FBC59504B2]
Development of an assay by liquid chromatography coupled to tandem mass spectrometry for thiopurines drugs in whole blood and application for their Therapeutic Drug Monitoring
Nguyen N., Da Silva Pereira Clara J. A., Mercier T., Desfontaines V., Ceppi F., Moradpour D., Chtioui H., André P., Buclin T., Decosterd L. A. et al., 2022/06/01. dans 6ème Congrès de printemps de la Société Suisse de Médecine Interne Générale du 1er juin 2022.
[URN][serval:BIB_144D7BE019DE]
Multifocal lymphadenopathies with polyclonal reactions primed after EBV infection in a mRNA-1273 vaccine recipient.
Girardin F.R., Tzankov A., Pantaleo G., Livio F., Greub G., 2022/05/23. Swiss medical weekly, 152 pp. w30188. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_378A2D414165]
Queries on medication use during pregnancy: characterisation of the Swiss Teratogen Information Service database.
Baumgartner R., Winterfeld U., Panchaud A., Simões-Wüst A.P., 2022/05/23. Swiss medical weekly, 152 pp. w30187. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C4A0898A24F9]
 
LC-MS/MS Peptide Assay Validation: A Plea for Robust Stability Studies.
Grouzmann E., Eugster P.J., 2022/05/18. Clinical chemistry, 68 (5) pp. 727-728. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CA6D770EF71E]
 
Telomere Length Declines in Persons With Human Immunodeficiency Virus Before Antiretroviral Therapy Start but Not After Viral Suppression: A Longitudinal Study Over >17 Years.
Schoepf I.C., Thorball C.W., Ledergerber B., Kootstra N.A., Reiss P., Raffenberg M., Engel T., Braun D.L., Hasse B., Thurnheer C. et al., 2022/05/04. The Journal of infectious diseases, 225 (9) pp. 1581-1591. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_39DB29D8297F]
Implications of Bariatric Surgery on the Pharmacokinetics of Antiretrovirals in People Living with HIV.
Zino L., Kingma J.S., Marzolini C., Richel O., Burger D.M., Colbers A., 2022/05. Clinical pharmacokinetics, 61 (5) pp. 619-635. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_514BD8F74357]
 
Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions.
Marzolini C., Kuritzkes D.R., Marra F., Boyle A., Gibbons S., Flexner C., Pozniak A., Boffito M., Waters L., Burger D. et al., 2022/05. Annals of internal medicine, 175 (5) pp. 744-746. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_70514994B951]
Scaling-up hepatitis C screening and treatment in Swiss outpatient psychiatric settings: A cost-effectiveness analysis.
Girardin F., Tuch A., Eddowes L., Preisig M., Negro F., 2022/05. JHEP reports, 4 (5) p. 100464. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E42C64DE613C]
Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study.
Gerbier E., Favre G., Tauqeer F., Winterfeld U., Stojanov M., Oliver A., Passier A., Nordeng H., Pomar L., Baud D. et al., 2022/04/27. International journal of environmental research and public health, 19 (9) p. 5335. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9A80E8D0D202]
Magnitude of Drug-Drug Interactions in Special Populations.
Bettonte S., Berton M., Marzolini C., 2022/04/04. Pharmaceutics, 14 (4). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AC9B5EC9062F]
Kinetics of neuropeptide Y, catecholamines, and physiological responses during moderate and heavy intensity exercises.
Eugster P.J., Bourdillon N., Vocat C., Wuerzner G., Nguyen T., Millet G.P., Grouzmann E., 2022/04. Neuropeptides, 92 p. 102232. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0096429CF785]
Model-based meta-analysis of salbutamol pharmacokinetics and practical implications for doping control.
Courlet P., Buclin T., Biollaz J., Mazzoni I., Rabin O., Guidi M., 2022/04. CPT, 11 (4) pp. 469-481. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F6F9604D8FA0]
Therapeutic drug monitoring of cefepime in a non-critically ill population: retrospective assessment and potential role for model-based dosing.
Suttels V., André P., Thoma Y., Veuve F., Decosterd L., Guery B., Buclin T., 2022/04. JAC-antimicrobial resistance, 4 (2) pp. dlac043. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F7941F21C4D1]
Multiplexed Assay to Quantify the PP-Fold Family of Peptides in Human Plasma Using Microflow Liquid Chromatography-Tandem Mass Spectrometry.
Reverter-Branchat G., Eugster P.J., Kuenzli C., Rindlisbacher B., Stauffer T., Nakas C.T., Herzig D., Grouzmann E., Bally L., 2022/03/31. Clinical chemistry, 68 (4) pp. 584-594. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_377C229CF8B6]
Hyperuricémie et maladie rénale : prise en charge [Management of hyperuricemia in chronic kidney disease]
Schwotzer N., Auberson M., Livio F., So A., Bonny O., 2022/03/02. Revue medicale suisse, 18 (771) pp. 379-384. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_2FCE48D8B05C]
Fluvoxamine for the treatment of COVID-19.
Marzolini C., Marra F., Boyle A., Khoo S., Back D.J., 2022/03. The Lancet. Global health, 10 (3) pp. e331. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A6D6B687283D]
HDLs extract lipophilic drugs from cells.
Zheng A., Dubuis G., Georgieva M., Mendes Ferreira C.S., Serulla M., Del Carmen Conde Rubio M., Trofimenko E., Mercier T., Decosterd L., Widmann C., 2022/03/01. Journal of cell science, 135 (5) pp. jcs258644. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_74F4A1CDF17E]
 
Physiologically Based Pharmacokinetic Modelling to Investigate the Impact of the Cytokine Storm on CYP3A Drug Pharmacokinetics in COVID-19 Patients.
Stader F., Battegay M., Sendi P., Marzolini C., 2022/03. Clinical pharmacology and therapeutics, 111 (3) pp. 579-584. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A0FD39599272]
 
Suspected Case of Drug-Induced Acute Respiratory Distress Syndrome following Trimethoprim-Sulfamethoxazole Treatment
Natterer Julia, Rizzati Frida, Perez Marie-Hélène, Longchamp David, Amiet Vivianne, DeHalleux Quentin, Dao Kim, Ferry Thomas, 2022/03. Journal of Pediatric Intensive Care, 11 (01) pp. 067-071.
[DOI][WoS][Pmid][serval:BIB_4DA842972028]
Dexamethasone is a dose-dependent perpetrator of drug-drug interactions: implications for use in people living with HIV.
Jacobs T.G., Marzolini C., Back D.J., Burger D.M., 2022/02/23. The Journal of antimicrobial chemotherapy, 77 (3) pp. 568-573. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2B2E67F2149C]
Dosing strategies of imipenem in neonates based on pharmacometric modelling and simulation.
Dao K., Fuchs A., André P., Giannoni E., Decosterd L.A., Marchetti O., Asner S.A., Pfister M., Widmer N., Buclin T. et al., 2022/02/02. The Journal of Antimicrobial Chemotherapy, 77 (2) pp. 457-465. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6EBEF14704F8]
Long-acting antiretrovirals: a new era for the management and prevention of HIV infection.
Thoueille P., Choong E., Cavassini M., Buclin T., Decosterd L.A., 2022/02/02. The Journal of antimicrobial chemotherapy, 77 (2) pp. 290-302. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C31B6241296B]
Pharmacovigilance - Vaccins à ARNm contre le Covid-19 : le point sur les effets indésirables [Pharmacovigilance - mRNA COVID-19 vaccines : current state of knowledge on their adverse effects]
Favre V., Ekobena P., Chtioui H., Rothuizen L.E., Livio F., Genton B., Buclin T., 2022/02/02. Revue medicale suisse, 18 (767) pp. 190-197. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C87F5371DEBD]
 
Parametric and Nonparametric Methods in Population Pharmacokinetics: Experts' Discussion on Use, Strengths, and Limitations.
Goutelle S., Woillard J.B., Buclin T., Bourguignon L., Yamada W., Csajka C., Neely M., Guidi M., 2022/02. Journal of clinical pharmacology, 62 (2) pp. 158-170. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E083EEFD4CCE]
 
Parametric Approaches in Population Pharmacokinetics.
Guidi M., Csajka C., Buclin T., 2022/02. Journal of clinical pharmacology, 62 (2) pp. 125-141. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4AEA287B02AD]
Use of Prescribed Drugs to Treat Chronic Diseases during Pregnancy in Outpatient Care in Switzerland between 2014 and 2018: Descriptive Analysis of Swiss Health Care Claims Data.
Gerbier E., Graber S.M., Rauch M., Marxer C.A., Meier C.R., Baud D., Winterfeld U., Blozik E., Surbek D., Spoendlin J. et al., 2022/01/27. International journal of environmental research and public health, 19 (3) p. 1456. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E15104835DDE]
Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries.
Ceulemans M., Foulon V., Panchaud A., Winterfeld U., Pomar L., Lambelet V., Cleary B., O'Shaughnessy F., Passier A., Richardson J.L. et al., 2022/01/26. International journal of environmental research and public health, 19 (3) p. 1389. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_16ABC557777C]
Prevalence and Factors Associated with Opioid Prescription in Swiss Chronic Hemodialysis Patients
Hennebel Clémence, Vilmont Valérie, Cherpillod Anne, Fumeaux David, Fakhouri Fadi, Livio Françoise, Burnier Michel, Pruijm Menno, 2022/01/02. Kidney and Dialysis, 2 (1) pp. 6-15.
[URN][DOI][serval:BIB_01CCFE785454]
Accurate Location of Catheter Tip With the Free-to-Total Metanephrine Ratio During Adrenal Vein Sampling.
Christou F., Pivin E., Denys A., Abid K.A., Zingg T., Matter M., Pechère-Bertschi A., Maillard M., Grouzmann E., Wuerzner G., 2022. Frontiers in endocrinology, 13 p. 842968. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CF212A67D096]
Brain fog in neuropathic postural tachycardia syndrome may be associated with autonomic hyperarousal and improves after water drinking.
Rodriguez B., Hochstrasser A., Eugster P.J., Grouzmann E., Müri R.M., Z'Graggen W.J., 2022. Frontiers in neuroscience, 16 p. 968725. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1ED1FCDC6149]
Cardiovascular therapy use, modification, and in-hospital death in patients with COVID-19: A cohort study.
Follonier C., Tessitore E., Handgraaf S., Carballo D., Achard M., Pechère-Bertschi A., Mach F., Herrmann F.R., Girardin F.R., 2022. PloS one, 17 (11) pp. e0277653. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_415F818E90D6]
 
Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance!
André P., Diezi L., Dao K., Crisinel P.A., Rothuizen L.E., Chtioui H., Decosterd L.A., Diezi M., Asner S., Buclin T., 2022. Frontiers in pediatrics, 9 p. 768438. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B465A6064AF2]
Iberogast®-Induced Acute Liver Injury-A Case Report.
Leroy A., Perrin H., Porret R., Sempoux C., Chtioui H., Fraga M., Bart P.A., 2022. Gastro hep advances, 1 (4) pp. 601-603. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_5E2F0FB82317]
Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertension.
Mühlethaler-Mottet A., Uccella S., Marchiori D., La Rosa S., Daraspe J., Balmas Bourloud K., Beck Popovic M., Eugster P.J., Grouzmann E., Abid K., 2022. Frontiers in endocrinology, 13 p. 1027856. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7CBCA91E69DA]
Pharmacogenomic-guided clozapine administration based on HLA-DQB1, HLA-B and SLCO1B3-SLCO1B7 variants: an effectiveness and cost-effectiveness analysis.
Ninomiya K., Saito T., Ikeda M., Iwata N., Girardin F.R., 2022. Frontiers in pharmacology, 13 p. 1016669. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0E1B390736D5]
 
Safety, tolerability and pharmacokinetic profile of Macozinone (PBTZ169) formulated as native crystal powder: multiple ascendingdoses, phase-Ib trial in healthy volunteers
Chtioui H., Prod'Hom S., Desfontaine V., André P., Moulfi F., Bardinet C., Abo-Loha C., Tessieras J., Rothuizen L.E., Diezi L. et al., 2022. dans 15th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT) - June 2022 Athens. European Journal of Clinical Pharmacology, 2022, 78: 1-163.
[serval:BIB_F1F116FD908F]
 
Safety, tolerability, pharmacokinetic profile and ex-vivo antitubercular acativity of macozinone formulated as spraydredi dispersion (SDD) versus native crystal powder (NCO?: single ascending doses, randomized, placebo-controlled, cross-ouver phase la trial in healthy volunteers
Rothuizen L.E., Ciullini L., Huser-Pitteloud J., Guidi M., Chtioui H., Ivanyuk A., André P., Bardinet C., Decosterd L.A., Spaggiari D. et al., 2022. dans SGAIM/SSMIG 6th Spring Congress Lausanne, June 2022. Primary and Hospital Care 2022: 22 (Suppl. 12), 173.
[serval:BIB_B502CD64B984]
Therapeutic drug monitoring of newer generation antiseizure medications at the point of treatment failure.
Fluckiger P., Aícua-Rapún I., André P., Rossetti A.O., Decosterd L.A., Buclin T., Novy J., 2022/01. Seizure, 94 pp. 66-69. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3FCED610441B]
2021
Symptoms and quality of life at 1-year follow up of patients discharged after an acute COVID-19 episode.
Tessitore E., Handgraaf S., Poncet A., Achard M., Höfer S., Carballo S., Marti C., Follonier C., Girardin F., Mach F. et al., 2021/12/06. Swiss medical weekly, 151 pp. w30093. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_407CF11BBB60]
Pembrolizumab-induced massive hypereosinophilia associated with mononeuritis multiplex, brain microvascular lesions and intestinal eosinophilic infiltration in a melanoma patient
Dao Kim, Kuntzer Thierry, Maeder Philippe, Frossard Valerie, Livio Francoise, 2021/12. Current Problems in Cancer: Case Reports, 4 p. 100133.
[URN][DOI][serval:BIB_AA9DB950A542]
Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial.
Labhardt N.D., Smit M., Petignat I., Perneger T., Marinosci A., Ustero P., Diniz Ribeiro M.P., Ragozzino S., Nicoletti G.J., Faré P.B. et al., 2021/12. EClinicalMedicine, 42 p. 101188. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D190F50E05B1]
Use of drugs to treat symptoms and acute conditions during pregnancy in outpatient care in Switzerland between 2014 and 2018: analysis of Swiss healthcare claims data.
Gerbier E., Graber S.M., Rauch M., Marxer C.A., Meier C.R., Baud D., Winterfeld U., Blozik E., Surbeki D., Spoendlin J. et al., 2021/11/22. Swiss medical weekly, 151 pp. w30048. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_DF3C0B2E7521]
 
Therapeutic drug monitoring in a patient with very advanced XDR-TB
Lange C., Köhler N., Choong E., Decosterd L.A., 2021/11/11. dans International Workshop on Clinical Pharmacology of Tuberculosis Drugs.
[serval:BIB_2C149D176B4A]
 
Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trial.
Courlet P., Barbieux C., Sculier D., Wandeler G., Stoeckle M., Bernasconi E., Braun D., Vernazza P., Cavassini M., Marinosci A. et al., 2021/11. British journal of clinical pharmacology, 87 (11) pp. 4455-4460. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_87880AB3A5A2]
Physiologically-Based Pharmacokinetic Modeling to Support the Clinical Management of Drug-Drug Interactions With Bictegravir.
Stader F., Battegay M., Marzolini C., 2021/11. Clinical pharmacology and therapeutics, 110 (5) pp. 1231-1239. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_59A26B555DD0]
 
Prevalence of Potential Drug-Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors.
Deutschmann E., Bucher H.C., Jaeckel S., Gibbons S., McAllister K., Scherrer A.U., Braun D.L., Cavassini M., Hachfeld A., Calmy A. et al., 2021/10/05. Clinical infectious diseases, 73 (7) pp. e2145-e2152. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D84973BFC460]
 
Associations Between Maternal Depression, Antidepressant Use During Pregnancy, and Adverse Pregnancy Outcomes: An Individual Participant Data Meta-analysis.
Vlenterie R., van Gelder MMHJ, Anderson H.R., Andersson L., Broekman BFP, Dubnov-Raz G., El Marroun H., Ferreira E., Fransson E., van der Heijden FMMA et al., 2021/10/01. Obstetrics and gynecology, 138 (4) pp. 633-646. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BB6C35053F66]
 
Drugs Associated With Ischemic Stroke: A Review for Clinicians.
Marto J.P., Strambo D., Livio F., Michel P., 2021/10. Stroke, 52 (10) pp. e646-e659. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3D9827F6900A]
 
Phase I Dose-Escalation Study of the Dual PI3K-mTORC1/2 Inhibitor Gedatolisib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid Tumors.
Colombo I., Genta S., Martorana F., Guidi M., Frattini M., Samartzis E.P., Brandt S., Gaggetta S., Moser L., Pascale M. et al., 2021/09/15. Clinical cancer research, 27 (18) pp. 5012-5019. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F48454275B82]
Impact of the COVID-19 pandemic on Swiss pregnant and breastfeeding women - a cross-sectional study covering the first pandemic wave.
Lambelet V., Ceulemans M., Nordeng H., Favre G., Horsch A., Stojanov M., Winterfeld U., Baud D., Panchaud A., Pomar L., 2021/09/13. Swiss medical weekly, 151 pp. w30009. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AB7433408976]
 
Late Breaking Abstract - Therapeutic drug monitoring in a patient with very advanced XDR-TB
Choong Eva, Decosterd Laurent, 2021/09/05. dans Tuberculosis and non-tuberculous mycobacterial diseases. Peer-reviewed.
[DOI][serval:BIB_884325702B77]
Lactic acidosis and hyperlactatemia associated with lamivudine accumulation and sepsis in a kidney transplant recipient-a case report and review of the literature.
Hollinger A., Cueni N., Marzolini C., Dickenmann M., Landmann E., Battegay M., Martinez A.E., Siegemund M., Leuppi-Taegtmeyer A., 2021/09/04. AIDS research and therapy, 18 (1) p. 56. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_693CB6DBA95A]
Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases.
Burckhardt P., Faouzi M., Buclin T., Lamy O., The Swiss Denosumab Study Group, 2021/09. Journal of bone and mineral research, 36 (9) pp. 1717-1728. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3B3FDC4DE2B9]
 
Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on "Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199".
Stuckelberger S., Favre G., Ceulemans M., Gerbier E., Lambelet V., Stojanov M., Winterfeld U., Baud D., Panchaud A., Pomar L., 2021/08/05. Viruses, 13 (8) p. 1546. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6DD1C849D220]
 
Harmonization of LC-MS/MS Measurements of Plasma Free Normetanephrine, Metanephrine, and 3-Methoxytyramine.
Peitzsch M., Novos T., Kaden D., Kurlbaum M., van Herwaarden A.E., Müller D., Adaway J., Grouzmann E., McWhinney B., Hoad K. et al., 2021/08/05. Clinical chemistry, 67 (8) pp. 1098-1112. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6314F9E194B8]
Cross-cultural adaptation and psychometric validation of the revised Patients' Attitudes Towards Deprescribing (rPATD) questionnaire in French.
Roux B., Sirois C., Niquille A., Spinewine A., Ouellet N., Pétein C., Sibille F.X., Csajka C., Reeve E., Villeneuve C. et al., 2021/08. Research in social & administrative pharmacy, 17 (8) pp. 1453-1462. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0F9DB519D21F]
 
Seizure freedom and plasma levels of newer generation antiseizure medications.
Aícua-Rapún I., André P., Rossetti A.O., Décosterd L.A., Buclin T., Novy J., 2021/08. Acta neurologica Scandinavica, 144 (2) pp. 202-208. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1181D7D2379F]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University